vitreous surgery with intravitreal tissue plasminogen activator(t-PA)

vitreous surgery with intravitreal tissue plasminogen activator(t-PA) - vitreous surgery with intravitreal t-PA

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015282

Enrollment

Registered

2014-09-30

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

globe rupture

Interventions

Intravitreal injection of t-PA before vitreous surgery for globe rupture

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Globe rupture with a massive clot in the vitreous cavity

Exclusion criteria

Exclusion criteria: Patients with drug allergy for t-PA Pregnancy

Design outcomes

Primary

Measure	Time frame
Occurrence of adverse events after treatment	—

Countries

Japan

Contacts

Public ContactYusuke Shiode

Okayama University Hospital Department of Ophthalmology

shiode2001@yahoo.co.jp086-223-7151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026